High-throughput serum proteomics for the identification of protein biomarkers of mortality in older men

Eric Orwoll, Jack Wiedrick, Jon Jacobs, Erin S. Baker, Paul Piehowski, Vladislav Petyuk, Yuqian Gao, Tujin Shi, Richard D. Smith, Douglas C. Bauer, Steven R. Cummings, Carrie Nielson, Jodi Lapidus

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The biological perturbations associated with incident mortality are not well elucidated, and there are limited biomarkers for the prediction of mortality. We used a novel high-throughput proteomics approach to identify serum peptides and proteins associated with 5-year mortality in community-dwelling men age ≥65 years who participated in a longitudinal observational study of musculoskeletal aging (Osteoporotic Fractures in Men: MrOS). In a discovery phase, serum specimens collected at baseline in 2473 men were analyzed using liquid chromatography-ion mobility-mass spectrometry, and incident mortality in the subsequent 5 years was ascertained by tri-annual questionnaire. Rigorous statistical methods were utilized to identify 56 peptides (31 proteins) that were associated with 5-year mortality. In an independent replication phase, selected reaction monitoring was used to examine 21 of those peptides in baseline serum from 750 additional men; 81% of those peptides remained significantly associated with mortality. Mortality-associated proteins included a variety involved in inflammation or complement activation; several have been previously linked to mortality (e.g., C-reactive protein, alpha 1-antichymotrypsin) and others are not previously known to be associated with mortality. Other novel proteins of interest included pregnancy-associated plasma protein, VE-cadherin, leucine-rich α-2 glycoprotein 1, vinculin, vitronectin, mast/stem cell growth factor receptor, and Saa4. A panel of peptides improved the predictive value of a commonly used clinical predictor of mortality. Overall, these results suggest that complex inflammatory pathways, and proteins in other pathways, are linked to 5-year mortality risk. This work may serve to identify novel biomarkers for near-term mortality.

Original languageEnglish (US)
JournalAging Cell
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Proteomics
Biomarkers
Mortality
Serum
Proteins
Peptides
Blood Proteins
alpha 1-Antichymotrypsin
Proto-Oncogene Proteins c-kit
Vinculin
Independent Living
Vitronectin
Osteoporotic Fractures
Stem Cell Factor
Growth Factor Receptors
Complement Activation
Leucine
Liquid Chromatography
C-Reactive Protein
Observational Studies

Keywords

  • Aging
  • Biomarker
  • Inflammation
  • Men
  • Mortality
  • Proteomics

ASJC Scopus subject areas

  • Aging
  • Cell Biology

Cite this

High-throughput serum proteomics for the identification of protein biomarkers of mortality in older men. / Orwoll, Eric; Wiedrick, Jack; Jacobs, Jon; Baker, Erin S.; Piehowski, Paul; Petyuk, Vladislav; Gao, Yuqian; Shi, Tujin; Smith, Richard D.; Bauer, Douglas C.; Cummings, Steven R.; Nielson, Carrie; Lapidus, Jodi.

In: Aging Cell, 01.01.2018.

Research output: Contribution to journalArticle

Orwoll, E, Wiedrick, J, Jacobs, J, Baker, ES, Piehowski, P, Petyuk, V, Gao, Y, Shi, T, Smith, RD, Bauer, DC, Cummings, SR, Nielson, C & Lapidus, J 2018, 'High-throughput serum proteomics for the identification of protein biomarkers of mortality in older men', Aging Cell. https://doi.org/10.1111/acel.12717
Orwoll, Eric ; Wiedrick, Jack ; Jacobs, Jon ; Baker, Erin S. ; Piehowski, Paul ; Petyuk, Vladislav ; Gao, Yuqian ; Shi, Tujin ; Smith, Richard D. ; Bauer, Douglas C. ; Cummings, Steven R. ; Nielson, Carrie ; Lapidus, Jodi. / High-throughput serum proteomics for the identification of protein biomarkers of mortality in older men. In: Aging Cell. 2018.
@article{94b06590995148d0abdbe97a40f4f5c1,
title = "High-throughput serum proteomics for the identification of protein biomarkers of mortality in older men",
abstract = "The biological perturbations associated with incident mortality are not well elucidated, and there are limited biomarkers for the prediction of mortality. We used a novel high-throughput proteomics approach to identify serum peptides and proteins associated with 5-year mortality in community-dwelling men age ≥65 years who participated in a longitudinal observational study of musculoskeletal aging (Osteoporotic Fractures in Men: MrOS). In a discovery phase, serum specimens collected at baseline in 2473 men were analyzed using liquid chromatography-ion mobility-mass spectrometry, and incident mortality in the subsequent 5 years was ascertained by tri-annual questionnaire. Rigorous statistical methods were utilized to identify 56 peptides (31 proteins) that were associated with 5-year mortality. In an independent replication phase, selected reaction monitoring was used to examine 21 of those peptides in baseline serum from 750 additional men; 81{\%} of those peptides remained significantly associated with mortality. Mortality-associated proteins included a variety involved in inflammation or complement activation; several have been previously linked to mortality (e.g., C-reactive protein, alpha 1-antichymotrypsin) and others are not previously known to be associated with mortality. Other novel proteins of interest included pregnancy-associated plasma protein, VE-cadherin, leucine-rich α-2 glycoprotein 1, vinculin, vitronectin, mast/stem cell growth factor receptor, and Saa4. A panel of peptides improved the predictive value of a commonly used clinical predictor of mortality. Overall, these results suggest that complex inflammatory pathways, and proteins in other pathways, are linked to 5-year mortality risk. This work may serve to identify novel biomarkers for near-term mortality.",
keywords = "Aging, Biomarker, Inflammation, Men, Mortality, Proteomics",
author = "Eric Orwoll and Jack Wiedrick and Jon Jacobs and Baker, {Erin S.} and Paul Piehowski and Vladislav Petyuk and Yuqian Gao and Tujin Shi and Smith, {Richard D.} and Bauer, {Douglas C.} and Cummings, {Steven R.} and Carrie Nielson and Jodi Lapidus",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/acel.12717",
language = "English (US)",
journal = "Aging Cell",
issn = "1474-9718",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - High-throughput serum proteomics for the identification of protein biomarkers of mortality in older men

AU - Orwoll, Eric

AU - Wiedrick, Jack

AU - Jacobs, Jon

AU - Baker, Erin S.

AU - Piehowski, Paul

AU - Petyuk, Vladislav

AU - Gao, Yuqian

AU - Shi, Tujin

AU - Smith, Richard D.

AU - Bauer, Douglas C.

AU - Cummings, Steven R.

AU - Nielson, Carrie

AU - Lapidus, Jodi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The biological perturbations associated with incident mortality are not well elucidated, and there are limited biomarkers for the prediction of mortality. We used a novel high-throughput proteomics approach to identify serum peptides and proteins associated with 5-year mortality in community-dwelling men age ≥65 years who participated in a longitudinal observational study of musculoskeletal aging (Osteoporotic Fractures in Men: MrOS). In a discovery phase, serum specimens collected at baseline in 2473 men were analyzed using liquid chromatography-ion mobility-mass spectrometry, and incident mortality in the subsequent 5 years was ascertained by tri-annual questionnaire. Rigorous statistical methods were utilized to identify 56 peptides (31 proteins) that were associated with 5-year mortality. In an independent replication phase, selected reaction monitoring was used to examine 21 of those peptides in baseline serum from 750 additional men; 81% of those peptides remained significantly associated with mortality. Mortality-associated proteins included a variety involved in inflammation or complement activation; several have been previously linked to mortality (e.g., C-reactive protein, alpha 1-antichymotrypsin) and others are not previously known to be associated with mortality. Other novel proteins of interest included pregnancy-associated plasma protein, VE-cadherin, leucine-rich α-2 glycoprotein 1, vinculin, vitronectin, mast/stem cell growth factor receptor, and Saa4. A panel of peptides improved the predictive value of a commonly used clinical predictor of mortality. Overall, these results suggest that complex inflammatory pathways, and proteins in other pathways, are linked to 5-year mortality risk. This work may serve to identify novel biomarkers for near-term mortality.

AB - The biological perturbations associated with incident mortality are not well elucidated, and there are limited biomarkers for the prediction of mortality. We used a novel high-throughput proteomics approach to identify serum peptides and proteins associated with 5-year mortality in community-dwelling men age ≥65 years who participated in a longitudinal observational study of musculoskeletal aging (Osteoporotic Fractures in Men: MrOS). In a discovery phase, serum specimens collected at baseline in 2473 men were analyzed using liquid chromatography-ion mobility-mass spectrometry, and incident mortality in the subsequent 5 years was ascertained by tri-annual questionnaire. Rigorous statistical methods were utilized to identify 56 peptides (31 proteins) that were associated with 5-year mortality. In an independent replication phase, selected reaction monitoring was used to examine 21 of those peptides in baseline serum from 750 additional men; 81% of those peptides remained significantly associated with mortality. Mortality-associated proteins included a variety involved in inflammation or complement activation; several have been previously linked to mortality (e.g., C-reactive protein, alpha 1-antichymotrypsin) and others are not previously known to be associated with mortality. Other novel proteins of interest included pregnancy-associated plasma protein, VE-cadherin, leucine-rich α-2 glycoprotein 1, vinculin, vitronectin, mast/stem cell growth factor receptor, and Saa4. A panel of peptides improved the predictive value of a commonly used clinical predictor of mortality. Overall, these results suggest that complex inflammatory pathways, and proteins in other pathways, are linked to 5-year mortality risk. This work may serve to identify novel biomarkers for near-term mortality.

KW - Aging

KW - Biomarker

KW - Inflammation

KW - Men

KW - Mortality

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=85041307766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041307766&partnerID=8YFLogxK

U2 - 10.1111/acel.12717

DO - 10.1111/acel.12717

M3 - Article

JO - Aging Cell

JF - Aging Cell

SN - 1474-9718

ER -